Experts’ views on prostate cancer news from September 2021
23 September 2021

Experts’ views on prostate cancer news from September 2021

Learning objective:         

After watching this broadcast, participants should be able to:

  • Discuss and explain the recent data on prostate cancer from September 2021
  • Discuss how these recent data will affect and be integrated into daily clinical practice

 

Faculty:

  • Kurt Miller (Germany)
  • Heather Payne (UK)
  • Stephane Oudard (France)
  • Eleni Efstathiou (USA)
more info...

EM-67614
Charting the landscape for EGFR-positive NSCLC
24 September 2021

Charting the landscape for EGFR-positive NSCLC

Learning objective:         

After watching this broadcast, participants should be able to:

  • Evaluate developments in molecular testing for EGFRm+ NSCLC
  • Describe recent advances in the management of EGFR+ NSCLC and implications for the care of patients in clinical practice

 

Faculty:

  • Matthew Krebs (UK)
  • Antonio Passaro (Italy)
  • Reinhard Büttner (Germany)
  • Sanjay Popat (UK)
more info...

EM-69921
Experts’ views on bladder cancer news from September 2021
28 September 2021

Experts’ views on bladder cancer news from September 2021

Learning objective:         

After watching this broadcast, participants should be able to:

  • Discuss new data in bladder cancer
  • Integrate new data into the current disease landscape

 

Faculty:

  • Alison Birtle (UK)
  • Ignacio Duran (Spain)
  • Maria De Santis (Germany)
  • Fred Witjes (Netherlands)
more info...

EM-67608
Expanding horizons for the targeted management of EGFR-positive NSCLC
2 October 2021

Expanding horizons for the targeted management of EGFR-positive NSCLC

On demand Janssen satellite symposium from the virtual ESMO Congress 2021

Video recording by the congress organisers of the Janssen Symposium from the ESMO Congress 2021 that took place on 18 September.

Learning objective:         

After watching this broadcast, participants should be able to:

  • Reflect on novel management paradigms for patients with EGFR+ NSCLC, who are resistant to EGFR targeted therapies
  • Evaluate new and emerging diagnostic ...
more info...

EM-67433
Advances in the management of men with prostate cancer: Reflections on the last decade and perspectives for the future
3 October 2021

Advances in the management of men with prostate cancer: Reflections on the last decade and perspectives for the future

On demand Janssen satellite symposium from the virtual ESMO Congress 2021

In the last 10 years, important advancements in the treatment and management of patients with advanced prostate cancer were implemented in daily clinical practice. It is now the right time to reflect on what was achieved and to discuss the focus and development of management and new treatment options for men with prostate cancer in the years to come.

This ...

more info...

EM-67449
EGFR+ NSCLC in 2021: Key highlights of the year
15 December 2021

EGFR+ NSCLC in 2021: Key highlights of the year

Learning objective:         

After watching this broadcast, participants should be able to:

  • Describe key data on the diagnosis and management of patients with EGFR-positive NSCLC from 2021
  • Contextualise key learnings from 2021 into clinical practice through case study discussion and evaluation

 

Scientific Committee:

  • Matthew Krebs (UK)
  • Antonio Passaro (Italy)
more info...

EM-60991
;